DC Field | Value | Language |
---|---|---|
dc.contributor.author | J S Ryu | - |
dc.contributor.author | Eun-Jeong Jeong | - |
dc.contributor.author | J Y Kim | - |
dc.contributor.author | S J Park | - |
dc.contributor.author | W S Ju | - |
dc.contributor.author | C H Kim | - |
dc.contributor.author | Jang Seong Kim | - |
dc.contributor.author | Y K Choo | - |
dc.date.accessioned | 2022-04-29T06:20:56Z | - |
dc.date.available | 2022-04-29T06:20:56Z | - |
dc.date.issued | 2020 | - |
dc.identifier.issn | 1661-6596 | - |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/25864 | - |
dc.description.abstract | Mesenchymal stem cells (MSCs) are multipotent stem cells that can be isolated from various tissues in the adult body. MSCs should be characterized by three criteria for regenerative medicine. MSCs must (1) adhere to plastic surfaces, (2) express specific surface antigens, and (3) differentiate into mesodermal lineages, including chondrocytes, osteoblasts, and adipocytes, in vitro. Interestingly, MSCs have immunomodulatory features and secrete trophic factors and immune receptors that regulate the microenvironment in host tissue. These specific and unique therapeutic properties make MSCs ideal as therapeutic agents in vivo. Specifically, pre-clinical and clinical investigators generated inflammatory and fibrotic diseases models, and then transplantation of MSCs into diseases models for therapeutic effects investigation. In this review, we characterize MSCs from various tissues and describe their applications for treating various inflammation and fibrotic diseases. | - |
dc.publisher | MDPI | - |
dc.title | Application of mesenchymal stem cells in inflammatory and fibrotic diseases | - |
dc.title.alternative | Application of mesenchymal stem cells in inflammatory and fibrotic diseases | - |
dc.type | Article | - |
dc.citation.title | International Journal of Molecular Sciences | - |
dc.citation.number | 21 | - |
dc.citation.endPage | 8366 | - |
dc.citation.startPage | 8366 | - |
dc.citation.volume | 21 | - |
dc.contributor.affiliatedAuthor | Eun-Jeong Jeong | - |
dc.contributor.affiliatedAuthor | Jang Seong Kim | - |
dc.contributor.alternativeName | 유재성 | - |
dc.contributor.alternativeName | 정은정 | - |
dc.contributor.alternativeName | 김종엽 | - |
dc.contributor.alternativeName | 박순주 | - |
dc.contributor.alternativeName | 주원석 | - |
dc.contributor.alternativeName | 김창현 | - |
dc.contributor.alternativeName | 김장성 | - |
dc.contributor.alternativeName | 추영국 | - |
dc.identifier.bibliographicCitation | International Journal of Molecular Sciences, vol. 21, no. 21, pp. 8366-8366 | - |
dc.identifier.doi | 10.3390/ijms21218366 | - |
dc.subject.keyword | mesenchymal stem cells (MSCs) | - |
dc.subject.keyword | paracrine factors | - |
dc.subject.keyword | inflammatory disease | - |
dc.subject.keyword | fibrotic disease | - |
dc.subject.local | mesenchymal stem cells | - |
dc.subject.local | Mesenchymal stem cell | - |
dc.subject.local | Mesenchymal stem cells | - |
dc.subject.local | mesenchymal stem cells (MSCs) | - |
dc.subject.local | paracrine factors | - |
dc.subject.local | Inflammatory disease | - |
dc.subject.local | inflammatory disease | - |
dc.subject.local | Inflammatory diseases | - |
dc.subject.local | fibrotic disease | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.